Total Payments
$5,534
2024 Payments
$547.83
Companies
33
Transactions
271
Medicare Patients
1,332
Medicare Billing
$112,083
Payment Breakdown by Category
Food & Beverage$4,900 (88.5%)
Travel$367.34 (6.6%)
Education$243.78 (4.4%)
Other$22.60 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,900 | 259 | 88.5% |
| Travel and Lodging | $367.34 | 2 | 6.6% |
| Education | $243.78 | 9 | 4.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.60 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,028 | 68 | $0 (2024) |
| LivaNova USA, Inc. | $793.34 | 5 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $606.30 | 32 | $0 (2024) |
| Biogen, Inc. | $482.76 | 26 | $0 (2024) |
| Allergan, Inc. | $447.43 | 19 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $403.41 | 29 | $0 (2019) |
| UCB, Inc. | $256.57 | 10 | $0 (2018) |
| Lilly USA, LLC | $200.70 | 12 | $0 (2022) |
| Genentech USA, Inc. | $140.31 | 9 | $0 (2024) |
| SK Life Science, Inc. | $127.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $547.83 | 19 | ABBVIE INC. ($228.33) |
| 2023 | $816.48 | 45 | ABBVIE INC. ($593.28) |
| 2022 | $374.58 | 18 | ABBVIE INC. ($126.57) |
| 2021 | $140.61 | 8 | Allergan, Inc. ($42.36) |
| 2020 | $131.11 | 7 | Teva Pharmaceuticals USA, Inc. ($54.64) |
| 2019 | $546.03 | 30 | Biogen, Inc. ($146.07) |
| 2018 | $1,340 | 42 | LivaNova USA, Inc. ($793.34) |
| 2017 | $1,637 | 102 | Teva Pharmaceuticals USA, Inc. ($303.37) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 11 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2017 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $99.95 | General |
| 03/28/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, ZINBRYTA | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: NEUROLOGY | ||||||
| 03/21/2017 | Allergan Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: CNS | ||||||
| 03/14/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2017 | GENZYME CORPORATION | LUMIZYME (Drug), POMPE - DISEASE | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 02/15/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: CNS | ||||||
| 02/14/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2017 | Promius Pharma LLC | Zembrace (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Neurology | ||||||
| 02/01/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 01/26/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: CNS | ||||||
| 01/25/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: CNS | ||||||
| 01/17/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: NEUROLOGY | ||||||
| 01/17/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Central Nervous System | ||||||
| 01/17/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Central Nervous System | ||||||
| 01/17/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: Central Nervous System | ||||||
| 01/10/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 373 | 450 | $88,909 | $31,684 |
| 2022 | 8 | 290 | 373 | $71,479 | $25,891 |
| 2021 | 6 | 297 | 364 | $69,027 | $27,472 |
| 2020 | 14 | 372 | 436 | $66,961 | $27,035 |
Total Patients
1,332
Total Services
1,623
Medicare Billing
$112,083
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 116 | $24,360 | $9,109 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 90 | 108 | $22,680 | $6,358 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 35 | $7,770 | $3,510 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 26 | $7,670 | $2,898 | 37.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 15 | 25 | $6,505 | $2,197 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 40 | $6,000 | $1,889 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 28 | $3,276 | $1,706 | 52.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 11 | 20 | $2,500 | $1,464 | 58.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 12 | $3,540 | $1,127 | 31.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 24 | 24 | $2,208 | $990.43 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 16 | $2,400 | $435.54 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 90 | 120 | $25,200 | $7,977 | 31.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 15 | 39 | $4,875 | $3,567 | 73.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 37 | $7,770 | $3,289 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 50 | 62 | $9,300 | $2,774 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 27 | 29 | $8,555 | $2,483 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $7,410 | $2,239 | 30.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $2,442 | $1,143 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 18 | $2,700 | $908.78 | 33.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 15 | $1,755 | $821.87 | 46.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 16 | 16 | $1,472 | $687.65 | 46.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 84 | 106 | $21,660 | $7,487 | 34.6% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 21 | 38 | $5,010 | $3,534 | 70.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 33 | $6,370 | $3,193 | 50.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 55 | 69 | $9,860 | $3,073 | 31.2% |
About Dr. Amanda Nies, D.O
Dr. Amanda Nies, D.O is a Neurological Surgery healthcare provider based in Holland, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1639307093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amanda Nies, D.O has received a total of $5,534 in payments from pharmaceutical and medical device companies, with $547.83 received in 2024. These payments were reported across 271 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,900).
As a Medicare-enrolled provider, Nies has provided services to 1,332 Medicare beneficiaries, totaling 1,623 services with total Medicare billing of $112,083. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Location Holland, MI
- Active Since 06/24/2009
- Last Updated 01/12/2018
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1639307093
Products in Payments
- VNS Therapy (Device) $793.34
- UBRELVY (Drug) $486.95
- QULIPTA (Drug) $344.77
- GILENYA (Drug) $286.16
- BOTOX (Biological) $283.79
- TYSABRI (Biological) $217.65
- EMGALITY (Drug) $200.70
- BOTOX THERAPEUTIC (Biological) $182.71
- Briviact (Drug) $179.03
- VUMERITY (Drug) $174.08
- APTIOM (Drug) $125.19
- AUSTEDO (Drug) $122.02
- OCREVUS (Biological) $119.58
- COPAXONE (Drug) $91.99
- TECFIDERA (Drug) $91.03
- VYVGART (Drug) $84.38
- Austedo XR (Drug) $82.14
- Zembrace (Drug) $81.62
- BRIUMVI (Drug) $80.84
- Vimpat (Drug) $77.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.